HEALTHMEDPAGE TODAY
GLP-1 and SGLT2 Users Face Different Risk for Diabetic Foot Complication
A large, real-world analysis found that adults with type 2 diabetes using GLP-1 receptor agonists had significantly lower risks of major diabetic foot complications compared to those using SGLT2 inhibitors. The study highlights differing risk profiles between the two medication classes for diabetic foot outcomes.
Mentioned
Related Signal
Adjacent reporting
- The promises and pitfalls of GLP-1 drugs
- Add-On Orforglipron: Good News for Type 2 Diabetes and Inadequate Glycemic Control
- This cheap drug could help people with type 1 diabetes use less insulin
- Up to 40% of Diabetes Patients Achieved Normal HbA1c With Retatrutide
- The promises and pitfalls of GLP-1 drugs